fowlpox-prostate specific antigen vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2000 (NCT00005039)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Prostate specific antigenImmunity, active
KLK3 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fowlpox-prostate specific antigen vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00045227 | Phase 2 | Aug 1, 2002 | National Cancer Institute (NCI) |
| NCT00020254 | Phase 2 | Jun 1, 2000 | National Cancer Institute (NCI) |
| NCT00005039 | Phase 2 | Jan 1, 2000 | Harvard University, National Cancer Institute (NCI) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 3 | 3 | 1 | 2000 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2000 |
2 organizations
Page 1 / 1